Naveen Pemmaraju: Lindsay Rein on the latest developments in Systemic Mastocytosis at 16th International MPN Congress
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas, shared a post on X:
“Great talk by Dr. Lindsay Rein highlighting latest developments in Systemic Mastocytosis field at 16th Intl MPN Congress.”
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023